Vidaza and sepsis Patient Reports February 11, 2012

Vidaza Side Effects Report #5875517-3
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 22, 2008. Male patient, 86 years of age, weighting 146.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: delirium, diverticulitis, intestinal perforation, mental status changes, mood altered, pain , sepsis . Vidaza dosage: 50 MG/M2, DAILY X 5 DAYS, SUBCUTANEOUS. During the same period patient was treated with LEVOTHYROXINE, LORAZEPAM, MODAFINIL, ACETAMINOPHEN, ONDANSETRON, DIPHENHYDRAMINE, POTASSIUM. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5646849-9
Vidaza side effect was reported by a Physician from ITALY on Feb 18, 2008. Male patient, 80 years of age, weighting 213.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: renal failure, sepsis . Vidaza dosage: (150 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with DEPAKIN. Patient was hospitalized. Patient died on 01/16/2008.

Vidaza Side Effects Report #5286019-X
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 16, 2007. Male patient, 79 years of age, weighting 181.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, hypotension, hypoxia, pleural effusion, productive cough, renal failure, sepsis , sputum discoloured, sputum purulent. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with METFORMIN, ASPIRIN, DOXYCYCLINE, GUAIFENESIN, POTASSIUM. Patient was hospitalized. Patient died on 03/17/2007.

Vidaza Side Effects Report #5060546-2
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cerebrovascular accident, haemorrhage, pneumonia , sepsis . Vidaza dosage: unknown. During the same period patient was treated with LIPITOR, ATIVAN. Patient was hospitalized. Patient died on 02/16/2006.


Vidaza Side Effects Report #5166385-6
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemorrhage, pneumonia , renal failure, sepsis . Vidaza dosage: unknown. Patient was hospitalized. Patient died on 02/01/2006.

Vidaza Side Effects Report #5913562-X
Vidaza side effect was reported by a Physician from JAPAN on Sept 24, 2008. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pneumonia fungal, sepsis . Vidaza dosage: 75MG/M2, 7 X DAILY) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5925505-3
Vidaza side effect was reported by a Physician from JAPAN on Oct 01, 2008. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abscess , injection site erythema, pneumonia fungal, sepsis , staphylococcal infection . Vidaza dosage: 75 MG/M2, 7 X DAILY, SUBCUTANEOUS. During the same period patient was treated with WATERECTION, VORINCONAZOLE, BROTIZOLAM, LEVOFLOXACIN, RAMOSETRON HYDROCHLORIDE, HEPARINOID, HYDROCORTISONE NUTYRATE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4867503-7
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, injection site haemorrhage, injection site pain, intestinal ischaemia, multi-organ failure, renal failure, respiratory failure, sepsis , thrombosis mesenteric vessel. Vidaza dosage: 75 MG/M2 (DAILY X 5. Patient died on 08/23/2005.

Vidaza Side Effects Report #5953740-7
Vidaza side effect was reported by a Physician from ISRAEL on Nov 04, 2008. Female patient, 59 years of age, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome, leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: injection site reaction, pancytopenia, pericardial effusion, pleural effusion, sepsis . Vidaza dosage: unknown. During the same period patient was treated with BLOOD TRANSFUSION, INSULIN, STEROIDS. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5402040-2
Vidaza side effect was reported by a Physician from FRANCE on July 12, 2007. Male patient, 55 years of age, weighting 220.5 lb, was diagnosed with myelodysplastic syndrome, thrombosis prophylaxis, pyrexia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bacterial infection , catheter related infection, culture urine positive, escherichia infection, international normalised ratio increased, pneumonia klebsiella, sepsis . Vidaza dosage: 120 MG (DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with PREVISCAN, AMOXICILLIN, ATENOLOL. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5897620-4
Vidaza side effect was reported by a Physician from GERMANY on Sept 09, 2008. Male patient, 45 years of age, weighting 169.8 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bite, dysphagia, hypersensitivity, neutrophil count decreased, sepsis , soft tissue infection, swollen tongue, white blood cell count decreased. Vidaza dosage: (75 MG/M2), INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, ELECTROLYTES, ONDANSETRON, CEFTAZIDIM, PANTOPRAZOLE, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5467580-9
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 43 years of age, weighting 242.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , acute febrile neutrophilic dermatosis, post procedural haematoma, renal failure, respiratory failure, sepsis , vocal cord disorder. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5978037-0
Vidaza side effect was reported by a Physician from ISRAEL on Nov 24, 2008. Female patient, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome, leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: injection site reaction, pancytopenia, pericardial effusion, pleural effusion, sepsis . Vidaza dosage: unknown. During the same period patient was treated with BLOOD TRANSFUSION, INSULIN, STEROIDS. Patient was hospitalized. Patient died on 11/09/2008.

Vidaza Side Effects Report #5975636-7
Vidaza side effect was reported by a Pharmacist from FRANCE on Nov 20, 2008. Male patient was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, hyperthermia, sepsis . Vidaza dosage: 141MG DAILY. Patient was hospitalized. Patient died on 10/20/2008.


Vidaza Side Effects Report #6099529-2
Vidaza side effect was reported by a Pharmacist from FRANCE on Feb 19, 2009. Male patient was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, hyperthermia, sepsis . Vidaza dosage: 141MG DAILY. Patient was hospitalized. Patient died on 10/20/2008.